Editorial
The significance of pathological extracapsular vs. intracapsular lymph node involvement in patients with resectable esophageal cancer after neoadju-vant therapy
Abstract
The standard of care for locoregional esophageal cancer, regardless of histology, remains neoadjuvant chemotherapy or chemoradiation followed by an esophagectomy after restaging workup (1,2).
